Study of Efficacy and Safety of Ormeloxifene in the Management of Dysfunctional Menorrhagia
article
OA: bronze
CC0
AI-generated summary
This study found that ormeloxifene significantly reduced blood loss, increased hemoglobin, and decreased endometrial thickness in women with dysfunctional menorrhagia.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
ABSTRACT Objective To assess the efficacy and safety of ormeloxifene in the medical management of dysfunctional menorrhagia. Methodology Fifty women with menorrhagia were recruited for the study. Ormeloxifene 60 mg twice a week for 3 months from first day of periods and once a week for next 3 months was given. Mean blood loss (MBL) was assessed using pictorial blood loss assessment chart (PBAC). Ultrasonography (USG) and blood hemoglobin levels were done as baseline and at 2, 4 and 6 months of treatment. Side-effects of the drug were recorded. Changes in PBAC scoring, endometrial thickness (ET) and hemoglobin levels (Hb) were analyzed by student's paired ‘t’ tests using SPSS 17.0 version. p value . 0.05 was taken as significant. Results The pretreatment PBAC score was 360, which reduced to 209.5 at 2 months, 88.7 at 4 months and 68.2 at 6 months of treatment, which was statistically significant (p-value . 0.001). The rise in hemoglobin and decrease in ET, in women on ormeloxifene was also statistically significant (p-value . 0.001). Conclusion Ormeloxifene is an effective and safe therapeutic option for the medical management of menorrhagia. How to cite this article Gupta U, Shrivastava K, Katiyar G, Arif A, Gupta NK. Study of Efficacy and Safety of Ormeloxifene in the Management of Dysfunctional Menorrhagia. J South Asian Feder Menopause Soc 2014;2(1):1-4.
My notes (saved in your browser only)
Citation neighborhood (sparse)
Too few in-corpus citations on either side for a chart; here are the lists.
Cites (3)
References (12)
- Efficacy of a Selective Estrogen Receptor Modulator: ‘Ormeloxifene’ in Management of Dysfunctional Uterine Bleeding via openalex
- Medical management of dysfunctional uterine bleeding via openalex
- The Role of Sevista in the Management of Dysfunctional Uterine Bleeding via openalex
- W1992362081 via openalex
- W2022534203 via openalex
- W2064039265 via openalex
- W2085217616 via openalex
- W2105990762 via openalex
- W2339076815 via openalex
- W2495301793 via openalex
- W1969511375 via openalex
- W1973974063 via openalex
Source provenance
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0
· commercial use OK